Editas Medicine (EDIT) EBIT Margin (2015 - 2025)
Editas Medicine's EBIT Margin was -325.44% in Q3 2025, up 107323.74 percentage points from -107649.18% a year earlier and up 1115.14 percentage points from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) EBIT Margin (2015 - 2025) Analysis & Trends
On a trailing twelve-month basis, Editas Medicine's EBIT Margin was -428.71% through Sep 30, 2025, down 58.68 percentage points year-over-year; for FY2024, it came in at -777.22%, down 560.67 percentage points from FY2023.
- EBIT Margin shows a five-year change of -90.84 percentage points (FY2019 to FY2024).
- In earlier years, EBIT Margin was -216.56% in FY2023 (+929.70 pp), -1146.26% in FY2022 (-390.13 pp), -756.13% in FY2021 (-607.52 pp) and -148.61% in FY2020 (+537.77 pp).
- Quarterly EBIT Margin has moved between -136952.38% (Q3 2022) and -39.90% (Q4 2023) over five years.
- Compared with a year earlier, EBIT Margin has increased for three straight quarters, with an average year-over-year change of +50.26 percentage points over the last eight quarters.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2023 (a gain of 136012.29 percentage points); the worst was Q3 2022 (a drop of 136318.96 percentage points).
- Per Business Quant data, EDIT's EBIT Margin in the three quarters before Q3 2025 was -1440.58% (Q2 2025), -1635.10% (Q1 2025) and -152.24% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Editas Medicine | 234.09 Mn | -477.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -325.44% |
| Jun 30, 2025 | -1,440.58% |
| Mar 31, 2025 | -1,635.10% |
| Dec 31, 2024 | -152.24% |
| Sep 30, 2024 | -107,649.18% |
| Jun 30, 2024 | -14,016.18% |
| Mar 31, 2024 | -5,902.29% |
| Dec 31, 2023 | -39.90% |
| Sep 30, 2023 | -940.09% |
| Jun 30, 2023 | -1,527.33% |
| Mar 31, 2023 | -517.32% |
| Dec 31, 2022 | -970.72% |
| Sep 30, 2022 | -136,952.38% |
| Jun 30, 2022 | -852.47% |
| Mar 31, 2022 | -749.52% |
| Dec 31, 2021 | -333.71% |
| Sep 30, 2021 | -633.42% |
| Jun 30, 2021 | -14,617.68% |
| Mar 31, 2021 | -875.26% |
| Dec 31, 2020 | -576.86% |
API Access
Editas Medicine EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();